医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

More Than 400 Students of Zhangjiajie Daqiao Centre School Visited Jinchi Biotech Ltd.’s Giant Salamander Museum

2014年05月21日 AM02:00
このエントリーをはてなブックマークに追加


 

ZHANGJIAJIE, China

Jinchi Biotech Ltd., Since the Giant Salamander Museum opened to the public in 2010, it has played a significant role in the science education of Zhangjiajie local schools, and it was awarded national Science Education Base. On April 11, 2014, Zhangjiajie Giant Salamander Museum welcomed more than 400 students and teachers of Zhangjiajie Daqiao Centre School. During the guided tour the students were excited to learn a great deal of interesting knowledge about giant salamanders and in the quiz session after the tour they were able to answer most of the questions correctly. This has laid a solid foundation for the promotion of giant salamander knowledge as well as giant salamanders and environment protection among the student society.

On April 2014, a total of 31,713 tourists has visited the Giant Salamander Museum (excluding VIP and group tourists), which exhibited a 40.12% increase from April 2013.

ABOUT JINCHI

www.jc-biotech.com

Owning the world’s only Giant Salamander Museum, Jinchi Biotech Ltd. mainly specializes in the R&D of giant salamander related biotech products, with more than 40 skincare and health products under two product lines, namely SHINIQUE and ANDRIAS. With strong scientific research background and a comprehensive business model, Jinchi Biotech Ltd. values virtue and goodwill, commits to deliver quality products to consumers, and devotes to the health, beauty and biomedical industries.

Disclaimer

The statements contained herein are forward-looking statements that are subject to risks and uncertainties that could cause actual results to differ materially from those expressed in the forward-looking statements.

CONTACT

Jinchi Biotech Ltd.
Chan Luo, +86-731-8979-2661
ir@jc-biotech.com

Related Posts Plugin for WordPress, Blogger...

同じカテゴリーの記事 

  • サラダックス・バイオメディカル、サルバトーレ・J・サラモネ博士が権威ある C.E. Pippenger博士賞を受賞したと発表
  • Japan’s MHLW Approves PADCEV® (enfortumab vedotin) for Advanced Urothelial Cancer
  • VFMCRP announces approval for TAVNEOS® (avacopan) for the treatment of ANCA-associated vasculitis in Japan
  • TAE Life Sciences Announces Installation of First Accelerator-based Neutron Beam System for Biologically Targeted Radiation Therapy at Xiamen Humanity Hospital in China
  • New Study Evaluates the Feasibility of Using Masimo EMMA® Capnography on Mechanically Ventilated Neonates